首页> 外文期刊>BMC Microbiology >In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015
【24h】

In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015

机译:2014 – 2015年间来自卡塔尔的人类布鲁氏菌分离株的体外药敏试验

获取原文
           

摘要

Brucellosis is one of the most common zoonotic disease affecting humans and animals and is endemic in many parts of the world including the Gulf Cooperation Council region (GCC). The aim of this study was to identify the species and determine the antimicrobial susceptibility pattern of Brucella strains isolated from clinical specimens, from Qatar. We evaluated 231 Brucella isolates. All isolates were identified as B. melitensis. All the isolates were susceptible to doxycycline, tetracycline, streptomycin, gentamicin, trimethoprim / sulfamethoxazole and ciprofloxacin except rifampicin, where 48 % of the strains showed elevated MICs (1 mg/L). The rifampicin-resistance related hotspots within the rpoB gene were amplified and sequenced using PCR and no rpoB mutations were found in strains with rifampicin MICs of 2 mg/L. This study identified B. melitensis as the etiological agent of brucellosis in Qatar. No resistant isolates were detected among conventionally used antimicrobial agents.
机译:布鲁氏菌病是影响人类和动物的最常见的人畜共患病之一,在世界上许多地方都流行,包括海湾合作委员会地区(GCC)。这项研究的目的是鉴定从卡塔尔的临床标本中分离出的布鲁氏菌菌株的种类并确定其药敏模式。我们评估了231株布鲁氏菌。所有分离物均被鉴定为苜蓿芽孢杆菌。除利福平外,所有分离株均对多西环素,四环素,链霉素,庆大霉素,甲氧苄啶/磺胺甲恶唑和环丙沙星敏感,其中利福平除外,其中48%的菌株显示MIC升高(> 1 mg / L)。使用PCR对rpoB基因中耐利福平相关热点进行了扩增和测序,在rifampicin MICs> 2 mg / L的菌株中未发现rpoB突变。这项研究确定了B. melitensis是卡塔尔布鲁氏菌病的病原体。在常规使用的抗菌剂中未检测到耐药菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号